3.72
Anteris Technologies Global Corp 주식(AVR)의 최신 뉴스
Anteris Technologies Global (ASX:AVR shareholders incur further losses as stock declines 15% this week, taking three-year losses to 72% - simplywall.st
Anteris Technologies Global (ASX:AVR) investors are sitting on a loss of 66% if they invested three years ago - Yahoo
FY2026 Earnings Forecast for AVR Issued By Cantor Fitzgerald - Defense World
Anteris Technologies Strengthens Board with Key Appointments - MSN
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewswire
Anteris Technologies Announces Director Departure - TipRanks
Anteris Appoints David Roberts and Gregory Moss to its Board of Directors - GlobeNewswire Inc.
Kalkine: Leadership Reshuffle at Anteris (ASX:AVR) Highlights Strategic Growth Amid ASX200 Momentum - Kalkine Media
anteris technologies appoints new board members and announces resignation By Investing.com - Investing.com South Africa
Anteris Technologies Appoints New Board Members - TipRanks
anteris technologies appoints new board members and announces resignation - Investing.com
Anteris Technologies Expands CDI Issuance in Strategic Securities Adjustment - TipRanks
Anteris Technologies Announces Cessation of Securities - TipRanks
Analyzing MSA Safety (NYSE:MSA) & Anteris Technologies Global (NASDAQ:AVR) - Defense World
Anteris Technologies Global Corp’s Lock-Up Period Set To End on June 11th (NASDAQ:AVR) - Defense World
Millennium Management LLC Purchases Shares of 313,298 Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Will Anteris' DurAVR Spark A Paradigm Shift In The Transcatheter Aortic Valve Replacement Landscape? - RTTNews
Citadel Advisors LLC Makes New Investment in Anteris Technologies Global Corp (NASDAQ:AVR) - Defense World
Critical Survey: Anteris Technologies Global (NASDAQ:AVR) and Vicarious Surgical (NYSE:RBOT) - Defense World
Anteris Technologies advances toward PARADIGM trial after key regulatory and clinical milestones - Proactive financial news
Anteris Technologies Issues New Employee Incentive Securities - TipRanks
The morning catch up: ASX to extend gains as global optimism lifts markets - Proactive financial news
Anteris scales for pivotal PARADIGM Trial, plunging R&D investment into clinical activities - Proactive financial news
Anteris Technologies Advances Clinical Trial Efforts with DurAVR® THV - TipRanks
Anteris Technologies Reports Q1 2025 Results and Strategic Fund Allocation - TipRanks
Anteris Announces Results for the First Quarter of 2025 - The Manila Times
Earnings calendar for: - Yahoo
Modern-day gold prospectors in Stillwater are eying Wyoming, with plenty of investors backing them - Star Tribune
Anteris Technologies Files Amendment to Annual Report - TipRanks
Anteris Technologies Announces Cessation of Certain Securities - TipRanks
Anteris Technologies Global Corp. (AVR) Receives a Buy from Lake Street - The Globe and Mail
ASX Runners of the Week: Redstone Resources, Anteris & Jindalee Lithium - businessnews.com.au
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target By Investing.com - Investing.com South Africa
Cantor Fitzgerald maintains Anteris stock Overweight with $9 target - Investing.com
Anteris Technologies Announces New Securities Quotation - TipRanks
NanoVibronix (NASDAQ:NAOV) & Anteris Technologies Global (NASDAQ:AVR) Head to Head Review - Defense World
Anteris Technologies Reports March 2025 CDI Adjustments - TipRanks
Anteris Technologies Marks Clinical Milestone with DurAVR® THV By Investing.com - Investing.com Canada
Anteris reports over 100 patients treated with new heart valve By Investing.com - Investing.com South Africa
Anteris Technologies Hits Milestone with DurAVR® Heart Valve Treatment - Zenopa
Anteris Technologies Reaches Clinical Milestone: 100 patients treated with DurAVR® THV - GlobeNewswire
Anteris reports over 100 patients treated with new heart valve - Investing.com
Anteris Technologies announces 100 patients treated with DurAVR THV - TipRanks
Anteris Technologies Achieves Key Milestone in Cardiac Care - TipRanks
자본화:
|
볼륨(24시간):